Discover oncology · 2025
Chemoradiotherapy for recurrent CBTs case report.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Guangyu, Zhao Shuangyan, Wang Jiankai, Duan Xiaoyu, Cai Hongyi
Аннотация
BACKGROUND: Carotid body tumors (CBTs) are rare paragangliomas with an incidence of 1-2 per 100,000 individuals. While surgical resection remains the standard treatment, postoperative recurrence poses a clinical challenge.
CASE PRESENTATION: We describe a 49-year-old female with recurrent CBT involving the jugular foramen, managed with IGRT (60 Gy/30 fractions) and 4 cycles of CVD chemotherapy. Post-treatment RECIST evaluation revealed stable disease, supporting chemoradiotherapy as a salvage option for anatomically complex recurrences.
CONCLUSION: This case underscores the necessity for standardized protocols and further research to validate multimodal therapy in recurrent CBTs.
CASE PRESENTATION: We describe a 49-year-old female with recurrent CBT involving the jugular foramen, managed with IGRT (60 Gy/30 fractions) and 4 cycles of CVD chemotherapy. Post-treatment RECIST evaluation revealed stable disease, supporting chemoradiotherapy as a salvage option for anatomically complex recurrences.
CONCLUSION: This case underscores the necessity for standardized protocols and further research to validate multimodal therapy in recurrent CBTs.